Company Description
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China.
The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services.
As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province.
The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018.
Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
| Country | Hong Kong |
| Founded | 2009 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 1,202 |
| CEO | Ms. Ting Zheng |
Contact Details
Address: 48 Fl., Bank Of China Tower, 1 Garden Road Central Hong Kong, K3 000000 Hong Kong | |
| Phone | 852-3605-8180 |
| Website | globalcordbloodcorp.com |
Stock Details
| Ticker Symbol | CORBF |
| Exchange | OTCMKTS |
| Fiscal Year | April - March |
| Reporting Currency | CNY |
| CIK Code | 0001467808 |
| CUSIP Number | G39342103 |
| ISIN Number | KYG393421030 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Rui Arashiyama | Chief Executive Officer of Guangdong and Zhejiang Divisions |
| Ting Zheng | Chief Executive Officer and CEO of Beijing Division |
| Bing Chuen Chen | Chief Financial Officer |
| Xin Xu | Chief Technology Officer |
| Cathy Bai | Vice President of Corporate Finance |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 19, 2024 | 6-K | Report of foreign issuer |
| Jun 4, 2024 | 6-K/A | Filing |
| Jun 4, 2024 | 6-K | Report of foreign issuer |
| May 31, 2024 | 6-K | Report of foreign issuer |
| Apr 25, 2024 | 6-K | Report of foreign issuer |
| Apr 17, 2024 | 6-K | Report of foreign issuer |
| Mar 19, 2024 | 6-K | Report of foreign issuer |
| Mar 11, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Mar 11, 2024 | 6-K | Report of foreign issuer |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |